published meta-analysis   sensitivity analysis   studies

standard of care in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsRECOVERY (REGN-COV2), 2021 (REV) 1.25 [1.10; 1.43] 1.25[1.10; 1.43]RECOVERY (REGN-COV2), 2021 (REV)10%3,153NAnot evaluable deathsdetailed resultsRECOVERY (REGN-COV2), 2021 (REV) 1.25 [1.10; 1.43] 1.25[1.10; 1.43]RECOVERY (REGN-COV2), 2021 (REV)10%3,153NAnot evaluable death or ventilationdetailed resultsRECOVERY (REGN-COV2), 2021 (REV) 1.20 [1.09; 1.33] 1.20[1.09; 1.33]RECOVERY (REGN-COV2), 2021 (REV)10%3,083NAnot evaluable hospital dischargedetailed resultsRECOVERY (REGN-COV2), 2021 (REV) 0.84 [0.77; 0.92] 0.84[0.77; 0.92]RECOVERY (REGN-COV2), 2021 (REV)10%3,153NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-08-20 22:17 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 651 - roots T: 651